The diversity of neutralization epitopes in rotavirus VP4 is greater than previously appreciated by genomic typing methods.
Answers are grounded in this paper and cite their sources.
Rotavirus VP4 shows greater epitope diversity than genotyping captures; leaves open whether current surveillance informs vaccine strain selection.
In the present investigation we characterized the antigenic diversity of the VP4 and VP7 proteins in 309 and 261 human rotavirus strains isolated during two consecutive epidemic seasons, respectively, in three different regions of Mexico. G3 was found to be the prevalent VP7 serotype during the first year, being superseded by serotype G1 strains during the second season. To antigenically characterize the VP4 protein of the strains isolated, we used five neutralizing monoclonal antibodies (MAbs) which showed specificity for VP4 serotypes P1A, P1B, and P2 in earlier studies. Eight different patterns of reactivity with these MAbs were found, and the prevalence of three of these patterns varied from one season to the next. The P genotype of a subset of 52 samples was determined by PCR. Among the strains characterized as genotype P[4] and P[8] there were three and five different VP4 MAb reactivity patterns, respectively, indicating that the diversity of neutralization epitopes in VP4 is greater than that previously appreciated by the genomic typing methods.
No takes yet. Share an insight, caveat, or question.
Padilla-Noriega et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: